ArrowMark Financial Corp. (0001578987) (Filer)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of 

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) October 7, 2026

ArrowMark Financial Corp.

(Exact Name of Registrant as Specified in Charter)

Registrant’s telephone number, including area code (303) 398-2929

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

On October 7, 2026, ArrowMark Financial Corp., a registered closed-end investment company (the “Company”) entered into a Second Amendment to the Amended and Restated Credit Agreement dated May 27, 2022 (the “Agreement”) with Texas Capital Bank (the “Administrative Agent”), as administrative agent, and the lenders thereto, amending the terms of the Company’s existing Credit Agreement dated June 9, 2014 (as the same was amended from time to time, the “Existing Agreement”).

The Agreement modifies the Existing Agreement by, among other things, (i) increasing the maximum available revolving credit amount to $102,000,000 from $70,000,000, (ii) extending the facility’s maturity to the third anniversary of the Second Amendment date, and (iii) expanding the existing borrowing base to include additional eligible collateral. The Company intends to use the borrowing proceeds in furtherance of its investment objective by investing in banking-related investments and other securities, and to support its working capital needs.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.